Chongqing Zhifei Biological Products Co Ltd
SZSE:300122

Watchlist Manager
Chongqing Zhifei Biological Products Co Ltd Logo
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Watchlist
Price: 28.22 CNY -5.21% Market Closed
Market Cap: 67.7B CNY
Have any thoughts about
Chongqing Zhifei Biological Products Co Ltd?
Write Note

Relative Value

The Relative Value of one Chongqing Zhifei Biological Products Co Ltd stock under the Base Case scenario is 58.58 CNY. Compared to the current market price of 28.22 CNY, Chongqing Zhifei Biological Products Co Ltd is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
58.58 CNY
Undervaluation 52%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
86
Median 3Y
2.8
Median 5Y
3.8
Industry
7.7
Forward
1.4
vs History
84
vs Industry
10
Median 3Y
13.7
Median 5Y
18
Industry
22.7
Forward
9.7
vs History
92
vs Industry
11
Median 3Y
18.8
Median 5Y
36.7
Industry
21.6
vs History
73
vs Industry
3
Median 3Y
33.1
Median 5Y
46.7
Industry
25.2
vs History
92
vs Industry
42
Median 3Y
4.8
Median 5Y
6.2
Industry
2.5
vs History
90
vs Industry
76
Median 3Y
2.8
Median 5Y
3.9
Industry
7.7
Forward
1.4
vs History
88
vs Industry
56
Median 3Y
8.3
Median 5Y
10.5
Industry
9
vs History
84
vs Industry
11
Median 3Y
11.4
Median 5Y
15.3
Industry
4.2
Forward
8.2
vs History
84
vs Industry
9
Median 3Y
11.4
Median 5Y
15.3
Industry
4.1
Forward
8.3
vs History
92
vs Industry
11
Median 3Y
18.8
Median 5Y
37.8
Industry
5.7
vs History
82
vs Industry
8
Median 3Y
18.3
Median 5Y
28
Industry
3.6
vs History
92
vs Industry
47
Median 3Y
4.5
Median 5Y
6.2
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Chongqing Zhifei Biological Products Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
67.6B CNY 1.4 11.2 9.4 9.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average P/E: 175.4
11.2
7%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average EV/EBITDA: 16.1
9.4
7%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average EV/EBIT: 20.6
9.4
0%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top